Pharma Focus Europe

Fortrea Collaborates With Veeva and Advarra to Improve Patient and Site Experiences in Clinical Trials

Thursday, January 11, 2024

Fortrea (Nasdaq: FTRE) has recently announced a strategic industry collaboration with key partners Veeva Systems Inc. and Advarra, forming a leading global contract research organization (CRO). Veeva, a major provider of cloud solutions in the life sciences sector, and Advarra, specializing in clinical research technologies for sites and sponsors, join forces with Fortrea to create an integrated solution aimed at streamlining the clinical trial process and addressing industry challenges.

Recognizing the complexities faced by testing centers in conducting clinical trials, Fortrea, together with Veeva and Advarra, is establishing an alliance of industry partners to tackle these challenges. The focus is on overcoming administrative hurdles associated with multiple, often incompatible technologies, allowing testing centers to prioritize patient care and enhance the overall clinical trial experience.

The alliance brings forth a cohesive technology solution that combines the strengths of Fortrea's process expertise with best-in-class technologies from Veeva and Advarra. This integrated solution is designed to alleviate administrative burdens for both patients and trial sites, ultimately enhancing the accessibility of clinical trials to the public.

Mark Morais, Chief Operating Officer and President of Clinical Services at Fortrea, highlighted insights from their site advisory board, emphasizing the challenges posed by the array of technologies used in clinical trials. By collaborating with industry leaders like Veeva and Advarra, Fortrea aims to simplify the technological landscape, making a positive impact on site and patient experiences. Fortrea's unique position in the industry enables them to contribute their expertise to the technology and data ecosystems of their partners, fostering ongoing expansion of the alliance.

The partnership offers several benefits for testing centers, including a simplified cloud-based registration process, access to study technologies via a single dashboard, and a unified environment for study documents and records. Patients stand to gain from a user-friendly interface, step-by-step support throughout their study journey, and easy access to relevant studies through a self-referral function. Ongoing support and education are provided through an online portal or mobile app, and a simple application facilitates consenting and responding to results surveys.

Jim Reilly, Vice President of Veeva Development Cloud Strategy, expressed how Veeva's Clinical Platform applications would contribute to reducing patient participation burdens, streamlining trial site execution, and increasing transparency for sponsors.

Elisa Cascade, Chief Product Officer at Advarra, highlighted their commitment to revolutionizing clinical research and shared their enthusiasm for contributing Longboat solution and IRB services to the collaborative partnership. The use of the Longboat solution is expected to enhance protocol compliance and engagement of sites and patients throughout the clinical trial process.

 

Source: globenewswire.com

magazine-slider-img
Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva